Effect of race on outcome of white and black children with acute myeloid leukemia: The St. Jude experience

Pediatric Blood and Cancer

Volumn 48, Issue 1, 2007, Pages 10-15

  Rubnitz, Jeffrey E ^a   Lensing, Shelly ^a   Razzouk, Bassem I ^a,b   Pounds, Stanley ^a   Pui, Ching Hon ^a,b   Ribeiro, Ray C ^a,b  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

Author keywords

Acute myeloid leukemia; Race; Treatment outcome

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; AFRICAN AMERICAN; ARTICLE; CANCER SURVIVAL; CAUCASIAN; CHILD; CHILDHOOD LEUKEMIA; CLINICAL FEATURE; CLINICAL PROTOCOL; CYTOGENETICS; FEMALE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OUTCOMES RESEARCH; OVERALL SURVIVAL; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RACE DIFFERENCE; STATISTICAL SIGNIFICANCE;

ADOLESCENT; AFRICAN AMERICANS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; CHILD, PRESCHOOL; CLINICAL TRIALS; DISEASE-FREE SURVIVAL; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HOSPITALS, PEDIATRIC; HUMANS; INFANT; LEUKEMIA, MYELOCYTIC, ACUTE; MALE; REMISSION INDUCTION; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 33845297291     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.20878     Document Type: Article

References (20)

1. Howard J, Hankey BF, Greenberg RS, et al. A collaborative study of differences in the survival rates of black patients and white patients with cancer. Cancer 1992;69:2349-2360.
2. Bach PB, Schrag D, Brawley OW, et al. Survival of blacks and whites after a cancer diagnosis. J Am Med Assoc 2002;287:2106-2113.
3. Bradley CJ, Given CW, Roberts C. Disparities in cancer diagnosis and survival. Cancer 2001;91 :178-188.
4. Xie Y, Davies SM, Xiang Y, et al. Trends in leukemia incidence and survival in the United States (1973-1998). Cancer 2003;97:2229-2235.
5. Sekeres MA, Peterson B, Dodge RK, et al. Differences in prognostic factors and outcomes in African Americans and whites with acute myeloid leukemia. Blood 2004;103:4036-4042.
6. Bhatia S, Sather HN, Heerema NA, et al. Racial and ethnic differences in survival of children with acute lymphoblastic leukemia. Blood 2002;100:1957-1964.
7. Pollock BH, DeBaun MR, Camitta BM, et al. Racial differences in the survival of childhood B-precursor acute lymphoblastic leukemia: A Pediatric Oncology Group Study. J Clin Oncol 2000;18:813-823.
8. Kadan-Lottick NS, Ness KK, Bhatia S, et al. Survival variability by race and ethnicity in childhood acute lymphoblastic leukemia. J Am Med Assoc 2003;290:2008-2014.
9. Pui CH, Sandlund JT, Pei D, et al. Results of therapy for acute lymphoblastic leukemia in black and white children. J Am Med Assoc 2003;290:2001-2007.
10. Dahl GV, Kalwinsky DK, Mirro J Jr, et al. Allogeneic bone marrow transplantation in a program of intensive sequential chemotherapy for children and young adults with acute nonlymphocytic leukemia in first remission. J Clin Oncol 1990;8:295-303.
11. Kalwinsky D, Mirro J Jr, Schell M, et al. Early intensification of chemotherapy for childhood acute nonlymphoblastic leukemia: Improved remission induction with a five-drug regimen including etoposide. J Clin Oncol 1988;6:1134-1143.
12. Arnaout MK, Radomski KM, Srivastava DK, et al. Treatment of childhood acute myelogenous leukemia with an intensive regimen (AML-87) that individualizes etoposide and cytarabine dosages: Short- and long-term effects. Leukemia 2000;14:1736-1742.
13. Krance RA, Hurwitz CA, Head DR, et al. Experience with 2-chlorodeoxyadenosine in previously untreated children with newly diagnosed acute myeloid leukemia and myelodysplastic diseases. J Clin Oncol 2001;19:2804-2811.
14. Crews KR, Gandhi V, Srivastava DK, et al. Interim comparison of a continuous infusion versus a short daily infusion of cytarabine given in combination with cladribine for pediatric acute myeloid leukemia. J Clin Oncol 2002;20:4217-4224.
15. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959;22:719-748.
16. Kaplan EL, Meier P, Nonparametric estimation from incomplete observations. J Am Stat Assoc 1999;53:457-481.
17. Peto R, Pike MC, Armitage P, et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br J Cancer 1977;35:1-39.
18. Cox DR. Regression models and life-tables. J R Stat Soc B 1972;34:187-220.
19. Gray RJ. A class of K-sample tests for comparing the cumulative incidence of a competing risk. The Annual Stat 1988;16:1141-1154.
20. Pui CH, Relling MV, Downing JR. Acute lymphoblastic leukemia. N Engl J Med 2004;350:1535-1548.